Skip to main content

Clindamycin

NDC 25021-115 · Sagent Pharmaceuticals

Generic nameClindamycin Phosphate
Dosage formINJECTION, SOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)CLINDAMYCIN PHOSPHATE
Strength150 mg/mL
Pharmacologic classDecreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
Marketing categoryANDA

Packages

25021-115-02 — 25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIAL

25021-115-04 — 25 VIAL in 1 CARTON (25021-115-04) / 4 mL in 1 VIAL

25021-115-06 — 25 VIAL in 1 CARTON (25021-115-06) / 6 mL in 1 VIAL

Billed under HCPCS

J0736 — Injection, clindamycin phosphate, 300 mg Medicare Part B payment limit (ASP + 6%): $1.97

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16714-161 — Clindamycin Phosphate, 16714-246 — Clindamycin Phosphate, 16714-984 — clindamycin and benzoyl peroxide, 16781-462 — CLINDAMYCIN, 21922-002 — Clindamycin Phosphate Topical Solution USP, 1%, 21922-022 — CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, 21922-027 — Clindamycin Phosphate Gel USP, 1%, 21922-036 — Clindamycin Phosphate, 21922-050 — Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%, 21922-074 — CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, 43066-993 — Clindamycin phosphate, 43066-995 — Clindamycin phosphate, 43538-170 — clindamycin phosphate, 43538-172 — clindamycin phosphate, 43538-176 — clindamycin phosphate and benzoyl peroxide, 43538-179 — clindamycin phosphate, 45802-042 — clindamycin phosphate, 45802-128 — clindamycin phosphate, 45802-263 — Clindamycin Phosphate, 45802-383 — Clindamycin Phosphate and Benzoyl Peroxide, +111 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels